BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 280 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2021. The put-call ratio across all filers is 1.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,530,945 | -21.2% | 249,521 | -0.8% | 3.90% | -10.3% |
| Q2 2023 | $15,896,127 | +35.3% | 251,521 | -3.7% | 4.35% | +23.3% |
| Q1 2023 | $11,752,963 | +2.7% | 261,235 | 0.0% | 3.52% | +9.3% |
| Q4 2022 | $11,444,705 | -33.5% | 261,235 | 0.0% | 3.22% | -30.4% |
| Q3 2022 | $17,213,000 | +30.4% | 261,235 | -0.0% | 4.63% | +28.7% |
| Q2 2022 | $13,197,000 | -16.1% | 261,280 | +6.1% | 3.60% | -12.2% |
| Q1 2022 | $15,732,000 | -29.0% | 246,280 | +19.0% | 4.10% | -26.4% |
| Q4 2021 | $22,162,000 | +4.2% | 206,911 | 0.0% | 5.57% | -1.3% |
| Q3 2021 | $21,273,000 | +16.3% | 206,911 | -0.5% | 5.64% | +47.6% |
| Q2 2021 | $18,288,000 | -9.5% | 207,911 | 0.0% | 3.82% | -20.2% |
| Q1 2021 | $20,215,000 | -12.9% | 207,911 | +0.5% | 4.80% | -30.5% |
| Q4 2020 | $23,205,000 | +7.4% | 206,911 | -11.2% | 6.90% | -1.7% |
| Q3 2020 | $21,607,000 | +21.4% | 233,089 | +2.2% | 7.02% | +36.8% |
| Q2 2020 | $17,791,000 | +33.4% | 228,089 | 0.0% | 5.13% | -7.8% |
| Q1 2020 | $13,339,000 | +35.1% | 228,089 | +85.1% | 5.57% | +64.3% |
| Q4 2019 | $9,871,000 | +9.0% | 123,218 | 0.0% | 3.39% | -0.5% |
| Q3 2019 | $9,053,000 | -22.1% | 123,218 | 0.0% | 3.40% | -22.1% |
| Q2 2019 | $11,623,000 | +21.3% | 123,218 | +2.9% | 4.37% | +5.7% |
| Q1 2019 | $9,583,000 | +91.8% | 119,718 | +29.2% | 4.13% | +66.4% |
| Q4 2018 | $4,997,000 | -30.9% | 92,691 | 0.0% | 2.48% | -16.4% |
| Q3 2018 | $7,235,000 | +23.0% | 92,691 | 0.0% | 2.97% | +7.8% |
| Q2 2018 | $5,884,000 | -27.7% | 92,691 | +4.5% | 2.76% | -30.4% |
| Q1 2018 | $8,133,000 | +7.1% | 88,691 | -11.9% | 3.96% | -3.2% |
| Q4 2017 | $7,593,000 | +43.4% | 100,691 | +32.5% | 4.09% | +24.4% |
| Q3 2017 | $5,295,000 | +27.4% | 76,000 | -7.3% | 3.29% | +10.9% |
| Q2 2017 | $4,155,000 | +25.9% | 82,000 | -0.6% | 2.96% | +6.3% |
| Q1 2017 | $3,299,000 | +62.2% | 82,500 | +13.8% | 2.79% | +56.1% |
| Q4 2016 | $2,034,000 | +892.2% | 72,500 | +617.8% | 1.79% | +1003.1% |
| Q2 2016 | $205,000 | – | 10,100 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 645,539 | $69,144,000 | 7.84% |
| DAFNA Capital Management LLC | 206,911 | $22,162,000 | 5.57% |
| Eagle Health Investments LP | 192,639 | $20,634,000 | 5.03% |
| Casdin Capital, LLC | 1,550,000 | $166,021,000 | 4.68% |
| CADIAN CAPITAL MANAGEMENT, LP | 450,657 | $48,270,000 | 2.65% |
| Avidity Partners Management LP | 995,000 | $106,574,000 | 2.26% |
| Integral Health Asset Management, LLC | 75,000 | $8,033,000 | 2.22% |
| Rock Springs Capital Management LP | 859,755 | $92,088,000 | 2.13% |
| Boxer Capital, LLC | 507,374 | $54,345,000 | 2.11% |
| EFG Asset Management (North America) Corp. | 112,715 | $12,082,000 | 1.58% |